Navigation Links
PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
Date:11/20/2007

as a consultant on health outcomes to the U.K. Department of Health for more than 15 years. Dr. Kiri received an MSc degree in Operational Research from the University of Sussex and a Ph.D. from the University of Bradford, both located in the U.K. Dr. Kiri has been appointed as Adjunct Professor of Biostatistical Epidemiology at the University of Limerick in Ireland. His other academic appointments have included serving as a lecturer at the London School of Hygiene and Tropical Medicine and at the Department of Epidemiology at the University of Surrey, in the U.K. Dr. Kiri has been elected as a Chartered Statistician by the U.K. Royal Statistical Society.

Note: The International Society for Pharmacoepidemiology (ISPE) defines pharmacoepidemiology as the study of the utilization and effect of drugs in large numbers of people. ISPE defines epidemiology as the study of distribution and determinants of diseases in populations.

About PAREXEL International

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 64 locations throughout 51 countries around the world, and has approximately 7,000 employees. For more information about PAREXEL International visit

SOURCE PAREXEL International Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
7. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or ... development, marketing and distribution of opioid-related immunotherapies, announced ... with the Securities and Exchange Commission in connection ... be held on Thursday, September 4, 2014, at ... for determining those shareholders eligible to receive notice ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... Minn. , July 28, 2014  ANI Pharmaceuticals, ... the Company plans to release its second quarter and ... before the opening of the U.S. financial markets. The ... Relations section of the Company,s website, www.anipharmaceuticals.com . ... Chief Executive Officer, and Charlotte C. Arnold , ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... Ticketability.com has reduced the cost of Phantom of ... lower prices on the secure website. Customers are invited to ... tickets that are priced lower every day. , Click ... Ticketability.com. , Theatergoers know that attending an entertaining show can ... the Opera tickets for sale that are priced to fit ...
(Date:7/28/2014)... Treat skin to a true cleansing with the ... and tomorrow only (while supplies last), take 40% off at ... for two specific users: , 1) those with oily skin ... and , 2) aging skin to help reduce lines, exfoliate ... of Sublime Beauty®. , Those with oily skin can use ...
(Date:7/28/2014)... 29, 2014 NAPW honors ... County Hospital Center, as a 2014 Professional Woman of ... distinction for leadership in community health. As the largest, ... virtually every industry and profession, the National Association of ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:7/28/2014)... La Mirada, CA (PRWEB) July 28, 2014 ... anyone seeking to pilot an airplane, helicopter, gyroplan or ... training. Those hoping to pilot balloons and gliders are ... purpose of the physical exam is to alert potential ... or prevent safe aviation. By detecting these conditions early, ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook to ... Surgical Generators market. The report provides value, in ... average prices (in US dollars) within market segments ... Argon Plasma Coagulation Generators. , The report also ... each of these market categories, and global corporate-level ...
Breaking Medicine News(10 mins):Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Healthpointe Invites All Aspiring Pilots to Complete an FAA Certified Exam 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4
... SEATTLE, Aug. 5 On Thursday, August 6, 2009, ... Cell Therapeutics, Inc.,s (CTI) (Nasdaq and MTA: CTIC) management team will ... financial results. , , ... 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time, ...
... , , ... , SILVER SPRING, Md., Aug. 5 For ... an Obesity Medicine Physician Certification (OMPC) Examination. The 18-month process of ... with an expected completion in March 2010. According to Dr. Robert ...
... , SAN FRANCISCO, Aug. 4 More ... Francisco Wednesday to protest gaps by California hospitals in safety preparation ... announced today. , , The nurses ... blew the whistle on unsafe patient care involving swine flu at ...
... , , ... ViroPharma Incorporated (Nasdaq: VPHM ... Committee supports the FDA,s Office of Generic Drugs (OGD) draft guidelines ... used to treat severe, often life-threatening bacterial infections of the gastrointestinal ...
... , , WASHINGTON, Aug. ... announced financial results for the first quarter of its fiscal year ending ... to $57.2 million in the first quarter of fiscal 2009. Net ... million, or $0.36 per diluted share, for the same period a year ...
... , EAST RUTHERFORD, N.J., Aug. 4 Cambrex Corporation ... 30, 2009. , , Highlights , , ... impact of foreign currency. Reported sales declined by 9.8% for the quarter. , ... in the same quarter last year (see attached table). , ...
Cached Medicine News:Health News:Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 2Health News:100+ Nurses to Rally in SF Wed. to Demand Stronger Swine Flu Safety Protections: California Hospitals Remain Unprepared Despite First Nurse Death 2Health News:100+ Nurses to Rally in SF Wed. to Demand Stronger Swine Flu Safety Protections: California Hospitals Remain Unprepared Despite First Nurse Death 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 2Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 4Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 10Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 11Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 12Health News:Cambrex Reports Second Quarter 2009 Results 2Health News:Cambrex Reports Second Quarter 2009 Results 3Health News:Cambrex Reports Second Quarter 2009 Results 4Health News:Cambrex Reports Second Quarter 2009 Results 5Health News:Cambrex Reports Second Quarter 2009 Results 6Health News:Cambrex Reports Second Quarter 2009 Results 7Health News:Cambrex Reports Second Quarter 2009 Results 8Health News:Cambrex Reports Second Quarter 2009 Results 9Health News:Cambrex Reports Second Quarter 2009 Results 10Health News:Cambrex Reports Second Quarter 2009 Results 11Health News:Cambrex Reports Second Quarter 2009 Results 12
... consisting of 38 cobbs, osteotomes, elevators, ... spine. The instruments extra (15) length ... best applied in thoracic, lumbar and ... for surgeons to pick and choose ...
... growth factors (AGF) technology. Using ... AGF gel delivers a cocktail ... and proteins in high concentrations ... of new bone cells and ...
With the Leica D2D V3 video and photography system you can produce fantastic digital videos and pictures with the highest resolution....
... Headlight mounted micro video camera has been ... in areas otherwise invisible to all but ... The system may be used for all ... crowding of the sterile area and enabling ...
Medicine Products: